H4 receptors in mast cells and basophils: A new therapeutic target for allergy?

Frontiers in Bioscience

Volumn 17, Issue 2, 2012, Pages 430-437

  Gibbs, Bernhard F ^a   Levi Schaffer, Francesca ^b  

^a UNIVERSITY OF KENT   (United Kingdom)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Allergy; Basophils; Histamine; IgE; Mast cells; Review

Indexed keywords

EID: 84860345408     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3936     Document Type: Article

References (85)

1. M Arock, E Schneider, M Boissan, V Tricottet, M Dy: Differentiation of human basophils: an overview of recent advances and pending questions. J Leukocyte Biol 71, 557- 564 (2002).
2. FH Falcone, H Haas, BF Gibbs: The human basophil: a new appreciation of its role in immune responses. Blood 96, 4028-4038 (2000).
3. AG Leary, M Ogawa: Identification of pure and mixed basophil colonies in culture of human peripheral blood and marrow cells. Blood 64, 78-83 (1984). (Pubitemid 14085730)
4. JA Denburg, S Telizyn, H Messner, B Lim, N Jamal, SJ Ackerman, GJ Gleich, J Bienenstock: Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor. Blood 66, 312-318 (1985). (Pubitemid 15007019)
5. SC Weil, MA Hrisinko: A hybrid eosinophilic-basophilic granulocyte in chronic granulocytic leukemia. Am J Clin Pathol 87, 66-70 (1987). (Pubitemid 17216827)
6. CL Kepley, JR Pfeiffer, LB Schwartz, BS Wilson, JM Oliver: The identification and characterization of umbilical cord blood-derived human basophils. J Leukoc Biol 64, 474-483 (1998). (Pubitemid 28455393)
7. AF Lopez, CL Sanderson, JR Gamble, HD Campbell, IG Young, MA Vadas: Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 167, 219-224 (1988). (Pubitemid 18093705)
8. H Agis, M Willheim, WR Sperr, A Wilfing, E Krömer, E Kabrna, E Spanblöchl, H Strobl, K Geissler, A Spittler, G Boltz-Nitulescu, O Majdic, K Lechner, P Valent: Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell. J Immunol 151, 4221-4227 (1993). (Pubitemid 23298755)
9. M Tsai, T Takeishi, H Thompson, KE Langley, KM Zsebo, DD Metcalfe, EN Geissler, SJ Galli: Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci U S A 88, 6382-6386 (1991). (Pubitemid 21914950)
10. Y Kitamura, S Go, K Hatanaka: Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 52, 447-452 (1978). (Pubitemid 8395558)
11. Y Kitamura, S Go: Decreased production of mast cells in Sl/Sld mice. Blood 53, 492-497 (1979). (Pubitemid 9140406)
12. H Nagai, T Sakurai, N Inagaki, H Mori: An immunopharmacological study of the biphasic allergic skin reaction in mice. Biol Pharm Bull 18, 239-245. (1995).
13. CS Lantz, J Boesiger, CH Song, N Mach, T Kobayashi, RC Mulligan, Y Nawa, G Dranoff, SJ Galli: Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 392, 90-93 (1998). (Pubitemid 28150595)
14. LM Lichtenstein, BS Bochner: The role of basophils in asthma. Ann N Y Acad Sci 629, 48-61 (1991).
15. PC Atkins, LB Schwartz, NF Adkinson, C von Allmen, M Valenzano, B Zweiman: In vivo antigen-induced cutaneous mediator release: simultaneous comparisons of histamine, tryptase, and prostaglandin D2 release and the effect of oral corticosteroid administration. J Allergy Clin Immunol 86, 360-370 (1990). (Pubitemid 20305639)
16. T Koshino, S Teshima, N Fukushima, T Takaishi, K Hirai, Y Miyamoto, Y Arai, Y Sano, K Ito, Y Morita: Identification of basophils by immunohistochemistry in the airways of post-mortem cases of fatal asthma. Clin Exp Allergy 23, 919-295 (1993).
17. O Iliopoulos, FM. Baroody, RM. Naclerio, BS Bochner, A Kagey-Sobotka, LM Lichtenstein: Histamine containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol 148:2223-2228 (1992).
18. AM Irani, C Huang, HZ Xia, C Kepley, A Nafie, ED Fouda, S Craig, B Zweiman, LB Schwartz: Immunohistochemical detection of human basophils in latephase skin reactions. J Allergy Clin Immunol 101, 354-362 (1998). (Pubitemid 28146355)
19. M Arock, H Merle-Beral, B Dugas, F Ouaaz, L Le Goff, I Vouldoukis, JM Mencia-Huerta, C Schmitt, V Leblond-Missenard, P Debre: IL-4 release by human leukemic and activated normal basophils. J Immunol 151, 1441-1447 (1993). (Pubitemid 23219281)
20. T Brunner, CH Heusser, CA Dahinden: Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 177, 605-611 (1993). (Pubitemid 23104271)
21. DW MacGlashan, JM White, S Huang, SJ Ono, JT Schroeder, LM Lichtenstein: Secretion of IL-4 from human basophils: the relationship between IL-4 mRNA and protein in resting and stimulated basophils. J Immunol 152, 3006-3016 (1994). (Pubitemid 24097999)
22. BF Gibbs, H Haas, FH Falcone, C Albrecht, IB Vollrath, T Noll, HH. Wolff, U Amon: Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation. Eur J Immunol 26, 2493-2498 (1996). (Pubitemid 26340955)
23. B Ochensberger, G Daepp, S Rihs, CA Dahinden: Human blood basophils produce interleukin-13 in response to IgE-receptor-dependent and -independent activation. Blood 8, 3028-3037(1996). (Pubitemid 26357385)
24. KT Nouri-Aria, AM Irani, MR Jacobson, F O'brien, EM Varga, SJ Till, SR. Durham, LB Schwartz: Basophil recruitment and IL-4 production during human allergeninduced late asthma. J Allergy Clin Immunol 108, 205-211 (2001). (Pubitemid 32735402)
25. G Devouassoux, B Foster, LM Scott, DD Metcalfe, C Prussin: Frequency and characterization of antigen-specific IL-4- and IL-13- producing basophils and T cells in peripheral blood of healthy and asthmatic subjects. J Allergy Clin Immunol 104, 811-819 (1999). (Pubitemid 30249302)
26. Y Yanagihara, K Kajiwara, Y Basaki, K Ikizawa, M Ebisawa, C Ra, H Tachimoto, H Saito: Cultured basophils but not cultured mast cells induce human IgE synthesis in B cells after immunologic stimulation. Clin Exp Immunol 111, 136-143 (1998). (Pubitemid 28062789)
27. KG Huggins, J Brostoff: Local production of specific IgE antibodies in allergic-rhinitis patients with negative skin tests. Lancet 306, 148-150 (1975).
28. SR Durham, HJ Gould, QA Hamid: Local IgE production in nasal allergy. Int Arch Allergy Immunol, 113, 128-130 (1997). (Pubitemid 27160737)
29. S Balzar, M Strand, D Rhodes, SE Wenzel: IgE expression pattern in lung: relation to systemic IgE and asthma phenotypes. J Allergy Clin Immunol 119, 855-862 (2007). (Pubitemid 46546425)
30. HJ Gould, BJ Sutton, AJ Beavil, RL Beavil, N McCloskey, HA Coker, D Fear, L Smurthwaite: The biology of IgE and the basis of allergic disease. Annu Rev Immunol 21, 579-628 (2003). (Pubitemid 37174542)
31. A de Paulis, N Prevete, I Fiorentino, FW Rossi, S Staibano, N Montuori, P Ragno, A Longobardi, B Liccardo, A Genovese, D Ribatti, AF Walls, G Marone: Expression and functions of the vascular endothelial growth factors and their receptors in human basophils. J Immunol 177, 7322-7331 (2006). (Pubitemid 44715102)
32. JT Schroeder, DW MacGlashan, LM Lichtenstein: Human basophils: mediator release and cytokine production. Adv Immunol 77, 93-122 (2001). (Pubitemid 33703704)
33. BF Gibbs: Basophils as key regulators of allergic inflammation and Th2-type immunity. World Allergy Organization Journal 1, 123-128 (2008).
34. K Obata, K Mukai, Y Tsujimura, K Ishiwata, Y Kawano, Y Minegishi, N Watanabe, H Karasuyama: Basophils are essential initiators of a novel type of chronic allergic inflammation. Blood 110, 913-920 (2007). (Pubitemid 47267429)
35. K Mukai, K Matsuoka, C Taya, H Suzuki, H Yokozeki, K Nishioka, K Hirokawa, M Etori, M Yamashita, T Kubota, Y Minegishi, H Yonekawa, H Karasuyama: Basophils play a critical role in the development of IgEmediated chronic allergic inflammation independently of T cells and mast cells. Immunity 23, 191-202 (2005). (Pubitemid 41169288)
36. T Yoshimoto, K Yasuda, H Tanaka, M Nakahira, Y Imai, Y Fujimori, K Nakanishi: Basophils contribute to T(H)2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells. Nat Immunol 10, 706-712 (2009).
37. CL Sokol, NQ Chu, S Yu, SA Nish, TM Laufer, R Medzhitov: Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat Immunol 10, 713-720 (2009).
38. JG Perrigoue, SA Saenz, MC Siracusa, EJ Allenspach, BC Taylor, PR Giacomin, MG Nair, Y Du, C Zaph, N van Rooijen, MR Comeau, EJ Pearce, TM Laufer, D Artis: MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity. Nat Immunol 10, 697-705 (2009).
39. JF Riley, GB West: Histamine in tissue mast cells. J Physiol 117, 72-73 (1952).
40. C Prinz, R Zanner, M Gerhard, S Mahr, N Neumayer, B Höhne-Zell, M Gratzl: The mechanism of histamine secretion from gastric enterochromaffin-like cells. Am J Physiol 277, C845-C855 (1999).
41. P Panula, K Karlstedt, T Sallmen, N Peitsaro, J Kaslin, KA Michelsen, O Anichtchik, T Kukko-Lukjanov and M Lintunen: The histaminergic system in the brain: structural characteristics and changes in hibernation. J Chem Neuroanat 18, 65-74 (2000). (Pubitemid 30120017)
42. HL Haas, OA Sergeeva, O Selbach: Histamine in the nervous system. Physiol Rev 88, 1183-241 (2008).
43. E Masini, MG Di Bello, S Raspanti, TB Sacchi, E Maggi, PF Mannaioni: Platelet aggregation and histamine release by immunological stimuli. Immunopharmacology 28, 19-29 (1994). (Pubitemid 24199273)
44. M Joseph, AS Gounni, JP Kusnierz, H Vorng, M Sarfati, JP Kinet, AB Tonnel, A Capron, M Capron: Expression and functions of the high-affinity IgE receptor on human platelets and megakaryocyte precursors. Eur J Immunol 27, 2212-2218 (1997). (Pubitemid 27404302)
45. G Zwadlo-Klarwasser, U Braam, P Mühl-Zürbes, W Schmutzler: Macrophages and lymphocytes: alternative sources of histamine. Agents Actions 41, C99-C100 (1994). (Pubitemid 24199944)
46. D MacGlashan: Histamine: A mediator of inflammation. J Allergy Clin Immunol 112 (4 Suppl), S53- S59 (2003).
47. BF Gibbs, A Rathling, D Zillikens, M Huber, H Haas: Initial Fc epsilon RI-mediated signal strength plays a key role in regulating basophil signaling and deactivation. J Allergy Clin Immunol 118, 1060-1067 (2006). (Pubitemid 44755179)
48. FH Falcone, D Zillikens, BF Gibbs: The 21st century renaissance of the basophil? Current insights into their role in allergic responses and innate immunity. Exp Dermatol 15, 855-864 (2006). (Pubitemid 44473324)
49. AM Piliponsky, D Pickholtz, GJ Gleich, F Levi- Schaffer: Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions. J Allergy Clin Immunol 107, 993-1000 (2001). (Pubitemid 32523338)
50. E Crivellato, B Nico, F Mallardi, CA Beltrami, D Ribatti: Piecemeal degranulation as a general secretory mechanism? Anat Rec A Discov Mol Cell Evol Biol 274, 778-784 (2003). (Pubitemid 37238376)
51. HR Bourne, KL Melmon, LM Lichtenstein: Histamine augments leukocyte adenosine 3́, 5́-monophosphate and blocks antigenic histamine release. Science 173, 743-745 (1971).
52. U Lippert, M Artuc, A Grützkau, M Babina, S Guhl, I Haase, V Blaschke, K Zachmann, M Knosalla, P Middel, S Krüger-Krasagakis, BM Henz: Human skin mast cells express H2 and H4, but not H3 receptors. J Invest Dermatol 123, 116-123 (2004). (Pubitemid 38833472)
53. LM Lichtenstein, E Gillespie: Inhibition of histamine release by histamine controlled by H2 receptor. Nature 244, 287-288 (1973).
54. SP Peters, ES Schulman, RP Schleimer, DW MacGlashan, HH Newball, LM Lichtenstein: Dispersed human lung mast cells. Pharmacologic aspects and comparison with human lung tissue fragments. Am Rev Respir Dis 126, 1034-1039 (1982). (Pubitemid 13202257)
55. R Summers, R Sigler, JH Shelhamer, M Kaliner: Effects of infused histamine on asthmatic and normal subjects: comparison of skin test responses. J Allergy Clin Immunol 67, 456-464 (1981). (Pubitemid 11117077)
56. W Kazimierczak, K Szczepaniak, K Bánkowska: A modulation of the anaphylactic basophil histamine release by selective H2 histamine agonists. Agents Actions 11, 96-98 (1981). (Pubitemid 11068390)
57. LM Botana, DW MacGlashan: Effect of cAMP-elevating drugs on stimulus-induced cytosolic calcium changes in human basophils. J Leukoc Biol 55, 798-804 (1994). (Pubitemid 24207412)
58. E Masini, P Blandina, S Brunelleschi, PF Mannaioni: Evidence for H2-receptor-mediated inhibition of histamine release from isolated rat mast cells. Agents Actions 12, 85-88 (1982). (Pubitemid 12076387)
59. J Stewart, AB Kay: Histamine increases histidine uptake by basophils. Clin Exp Immunol 40, 423-426 (1980). (Pubitemid 10113480)
60. BF Gibbs, IB Vollrath, C Albrecht, U Amon, HH. Wolff: Inhibition of interleukin-4 and interleukin-13 release from immunologically activated human basophils due to the actions of anti-allergic drugs. Naunyn Schmiedebergs Arch Pharmacol 357, 573-578 (1998). (Pubitemid 28255058)
61. F Levi-Schaffer, R Eliashar: Mast cell stabilizing properties of antihistamines. J Invest Dermatol 129, 2549-2551 (2009).
62. JM Palacios, M Garbarg, G Barbin, JC Schwartz: Pharmacological characterization of histamine receptors mediating the stimulation of cyclic AMP accumulation in slices from guinea-pig hippocampus. Mol Pharmacol 14, 971- 982 (1978). (Pubitemid 9093568)
63. A Tedeschi, M Lorini, M Arquati, A Miadonna: Regulation of histamine release from human basophil leucocytes: role of H1, H2 and H3 receptors. Allergy 46, 626- 631 (1991).
64. J Kleine-Tebbe, J Schramm, M Bolz, R Lipp, W Schunack, G Kunke: Influence of histamine H3-antagonists on human leukocytes. Agents Actions 30, 137-139 (1990). (Pubitemid 20142262)
65. JJ Rozniecki, R Letourneau, M Sugiultzoglu, C Spanos, J Gorbach, TC Theoharides: Differential effect of histamine 3 receptor-active agents on brain, but not peritoneal, mast cell activation. J Pharmacol Exp Ther 290, 1427-1435 (1999). (Pubitemid 29400288)
66. EY Bissonnette: Histamine inhibits tumor necrosis factor alpha release by mast cells through H2 and H3 receptors. Am J Respir Cell Mol Biol 14, 620-626 (1996). (Pubitemid 126442953)
67. A Nemmar, A Delaunois, JF Beckers, J Sulon, S Bloden, P Gustin: Modulatory effect of imetit, a histamine H3 receptor agonist, on C-fibers, cholinergic fibers and mast cells in rabbit lungs in vitro. Eur J Pharmacol 371, 23-30 (1999). (Pubitemid 29206458)
68. J Pyati, X Li, W Chai, N Carruthers, TW Lovenberg: Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol Pharmacol 59, 420-426 (2000).
69. KL Morse, J Behan, TM Laz, RE West, SA Greenfeder, JC Anthes, S Umland, Y Wan, RW Hipkin, W Gonsiorek, N Shin, EL Gustafson, X Qiao, S Wang, JA Hedrick, J Greene, M Bayne, FJ Monsma: Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther 296, 1058-1066 (2001). (Pubitemid 32187382)
70. CL Hofstra, PJ Desai, RL Thurmond, WP Fung-Leung: Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 305, 1212-1221 (2003). (Pubitemid 36618001)
71. K Takeshita, K Sakai, KB. Bacon, F Gantner: Critical role of histamine H4 receptor in leukotriene B4 production and mast cell dependent neutrophil recruitment induced by zymosan in vivo. J Pharmacol Exp Ther 307, 1072-1078 (2003). (Pubitemid 37494227)
72. RL Thurmond, PJ Desai, PJ Dunford, WP Fung-Leung, CL Hofstra, W Jiang, S Nguyen, JP Riley, S Sun, KN Williams, JP Edwards, L Karlsson: A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther 309, 404-413 (2004). (Pubitemid 38393154)
73. S Yu, E Stahl, Q Li, A Ouyang: Antigen inhalation induces mast cells and eosinophils infiltration in the guinea pig esophageal epithelium involving histamine-mediated pathway. Life Sci 82, 324-330 (2008).
74. V Godot, M Arock, G Garcia, F Capel, C Flys, M Dy, D Emilie, M Humbert: H4 histamine receptor mediates optimal migration of mast cell precursors to CXCL12. J Allergy Clin Immunol 120, 827-834 (2007). (Pubitemid 47531837)
75. MO'Reilly, R Alpert, S Jenkinson, RP Gladue, S Foo, S Trim, B Peter, M Trevethick, M Fidock: Identification of a histamine H4 receptor on human eosinophils-role in eosinophil chemotaxis. J Recept Signal Transduct Res 22, 431-448 (2002). (Pubitemid 36169163)
76. KF Buckland, TJ Williams, DM Conroy: Histamine induces cytoskeletal changes in human eosinophils via the H4 receptor. Br J Pharmacol 140, 1117-1127 (2003). (Pubitemid 37475978)
77. P Ling, K Ngo, S Nguyen, RL Thurmond, JP Edwards, L Karlsson, WP Fung-Leung: Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol 142, 161- 171 (2004). (Pubitemid 38698205)
78. E Zampeli, E Tiligada: The role of histamine H4 receptor in immune and inflammatory disorders. Br J Pharmacol 157, 24-33 (2009).
79. PJ Dunford, N O'Donnell, JP Riley, KN Williams, L Karlsson, RL Thurmond: The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T cells. J Immunol 176, 7062-7070 (2006). (Pubitemid 43787887)
80. RK Morgan, B McAllister, L Cross, DS Green, H Kornfeld, DM Center, WW Cruikshank: Histamine 4 receptor activation induces recruitment of FoxP3+ T cells and inhibits allergic asthma in a murine model. J Immunol 178, 8081-8089 (2007). (Pubitemid 46898080)
81. PJ Dunford, KN Williams, PJ Desai, L Karlsson, D McQueen, RL Thurmond: Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J Allergy Clin Immunol 119, 176-183 (2007). (Pubitemid 46037799)
82. K Rossbach, S Wendorff, K Sander, H Stark, R Gutzmer, T Werfel, M Kietzmann, W Bäumer: Histamine H4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation. Exp Dermatol 18, 57-63 (2009).
83. JM Cowden, M Zhang, PJ Dunford, RL Thurmond: The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. J Invest Dermatol 130, 1023-1033 (2010).
84. JM Cowden, JP Riley, JY Ma, RL Thurmond, PJ Dunford: Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokines. Respir Res 24, 11-86 (2010).
85. MI Strakhova, CA Cuff, AM Manelli, TL Carr, DG Witte, JL Baranowski, TA Vortherms, TR Miller, L Rundell, MJ McPherson, RM Adair, AA Brito, BM Bettencourt, BB Yao, JM Wetter, KC Marsh, H Liu, MD Cowart, JD Brioni, TA Esbenshade: In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory properties. Br J Pharmacol 157, 44-54 (2009).